Ricardo Menegatti

Design, synthesis and pharmacological profile of novel dopamine D2 receptor ligands

Ricardo Menegatti, Anna C. Cunha, Vı́tor F. Ferreira et al. · Bioorganic & Medicinal Chemistry · 2003 · 71 citations

Medicine, Medicinal Chemistry, Pharmacology +14

Searching for multi-target antipsychotics: Discovery of orally active heterocyclic N-phenylpiperazine ligands of D2-like and 5-HT1A receptors

Gilda Neves, Ricardo Menegatti, Camila B. Antonio et al. · Bioorganic & Medicinal Chemistry · 2010 · 64 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Design, synthesis, and pharmacological evaluation of new neuroactive pyrazolo[3,4-b]pyrrolo[3,4-d]pyridine derivatives with in vivo hypnotic and analgesic profile

Ricardo Menegatti, Gilberto M. S. Silva, Gisele Zapata‐Sudo et al. · Bioorganic & Medicinal Chemistry · 2005 · 49 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16

Involvement of the NO/cGMP/KATP pathway in the antinociceptive effect of the new pyrazole 5-(1-(3-fluorophenyl)-1H-pyrazol-4-yl)-2H-tetrazole (LQFM-021)

Iziara Ferreira Florentino, Pablinny Moreira Galdino, Lanussy Porfiro de Oliveira et al. · Nitric Oxide · 2015 · 40 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Potential anti-inflammatory effect of LQFM-021 in carrageenan-induced inflammation: The role of nitric oxide

Iziara Ferreira Florentino, Daiany Priscilla Bueno da Silva, Dayane M. Silva et al. · Nitric Oxide · 2017 · 40 citations

Medicine, Pharmacology, Inflammation +14